Rainbow Childrens Medicare Ltd
Rainbow Childrens Medicare Q4 FY25 earnings call: Revenue & Margins
Q4 FY25 earnings call: what management guided on revenue, margins and order book.
The short version
Rainbow Children's Medicare expects late teens to 20% revenue CAGR over the next 3 years, driven by a high-teens growth trajectory. Rainbow Children's Medicare expects revenue growth in the late teens to 20% range going forward.
From Rainbow Childrens Medicare Ltd's Q4 FY25 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Rainbow Children's Medicare expects late teens to 20% revenue CAGR over the next 3 years, driven by a high-teens growth trajectory.
- OPD revenue growth is expected to mirror overall revenue growth, maintaining around 30% contribution.
- ARPP (Average Revenue Per Patient) growth is forecasted around 5-6% annually, indicating underlying revenue efficiency.
- Mature hospitals typically achieve 8-10% growth; new hospitals scale occupancy before increasing pricing and ARPOB.
- Pediatric volumes experienced a 12% growth for the full year, with inpatient volumes up 10%. Deliveries grew 6%.
2 more points from Rainbow Childrens Medicare Ltd's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Rainbow Childrens Medicare Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- The company plans capital expenditures of around INR 650 crores over the next 3 years, consistent with previous guidance.
- Capex in the recent quarter was approximately INR 43.7 crores; full-year capex stood at INR 145.7 crores.
- New bed capacity addition of about 250 beds is planned, including ~150 beds in Bangalore and ~100 beds in Rajahmundry.
- The company expects to fund all planned capex from internal accruals and existing cash reserves (~INR 700 crores) without debt financing.
2 more points from Rainbow Childrens Medicare Ltd's call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Rainbow Childrens Medicare Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points from Rainbow Childrens Medicare Ltd's call on order book
Pro opens every point from 15K+ earnings calls
Rainbow Childrens Medicare Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹460 Cr, net profit ₹78 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Rainbow Childrens Medicare Ltd's management said in earlier quarters
Others in Healthcare Services this season
- 3B Blackbio (Q4 FY25)
UK subsidiary (TRUPCR Europe Limited) revenue FY 2024-25: GBP 1,287,580, a 94% increase over FY 2023-24 GBP 664,059. Key concall takeaways from 3B Blackbio DX…
- Apollo Hospitals Enterprise Ltd (Q4 FY25)
. Key concall takeaways from Apollo Hospitals Enterprise Ltd's Q4 FY25 earnings call — and how it ranks against sector peers.
- Shalby (Q4 FY25)
Implant business is in high-growth mode: 4x growth in Indonesia, 35-40% growth in U.S., and 2.5x growth in India reported last year. Key concall takeaways from…
- Suraksha Diagnostic Ltd (Q4 FY25)
Volume of tests conducted has been growing at around 10% year-on-year between FY '24 and FY '25. Key concall takeaways from Suraksha Diagnostic Ltd's Q4 FY25…
Arthneeti Pro · Annual
Rainbow Childrens Medicare Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Rainbow Childrens Medicare Ltd Q4 FY25 results?
Rainbow Children's Medicare expects late teens to 20% revenue CAGR over the next 3 years, driven by a high-teens growth trajectory. Rainbow Children's Medicare expects revenue growth in the late teens to 20% range going forward.
What is Rainbow Childrens Medicare Ltd share price analysis?
Rainbow Childrens Medicare Ltd currently shows a neutral. The stock trades at a P/E of 56.7 with a market cap of ₹16,236 Cr. Investors should review the full earnings analysis for detailed insights.
Is Rainbow Childrens Medicare Ltd planning capital expenditure?
The company plans capital expenditures of around INR 650 crores over the next 3 years, consistent with previous guidance.
Keep Rainbow Childrens Medicare Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.